What is Ethis HealthTech?
Ethis Healthtech, LLC, serves early-stage and emerging firms in the fields of eyecare and mobile/digital healthcare by providing market entry planning and support, and strategic communications. Working with both pre-revenue and later-stage firms, the Ethis Healthtech team can draw upon decades of experience in ophthalmology and optometry, technology and commercialization, construction of go-to-market strategies, management of sales teams, and implementation of all aspects of marketing and communications. With a deep network among ophthalmic and digital health multinationals, clinical key opinion leaders, and investors, Ethis Healthtech supports all aspects of its clients’ growth activities.
Who is Ethis HealthTech?
Luca Sergio is Owner and CEO of Ethis Communications and Managing Partner of Ethis HealthTech, the former being a marketing communications agency focused on ophthalmology and optometry and the latter being a consultancy addressing strategy and business development opportunities in eye care, digital health and beyond.
Luca has focused his energies on multinational technology commercialization, leading sales, marketing, and product development teams in the ophthalmic, dental, and infection control verticals. Most recently prior to taking the helm at Ethis, Luca served as Vice President of Sales, Americas, for Topcon Medical Systems, a Japanese ophthalmic diagnostic and healthcare IT firm, and earlier as Vice President of Marketing for WaveLight, Inc., a German ophthalmic surgical laser company.
His passions are all things eye care (on a global basis), healthcare social media, and particularly mHealth (mobilized healthcare) / healthcare IT. He was the architect of the first mHealth application / cloud system in ophthalmology, Topcon’s EyeRoute Synergy system.
Adam Gundaker is President and COO of Ethis Communications and Partner of Ethis Healthtech. Adam entered the eye care specialty in 2007 with Bausch + Lomb, where he held roles in sales, sales management, sales training, and marketing for Bausch + Lomb’s pharmaceutical division. Following his time at Bausch + Lomb, Adam balanced out his anterior segment commercial experience by gaining posterior segment experience as Associate Director of Marketing at ThromboGenics.
Clients find Adam’s key strengths to be understanding of the key players in the ophthalmic and optometric space, strategic thinking, outside-the-box tactical identification, attention to detail, clinical knowledge, and dedication.